作者: Luis A. Kluth , Evanguelos Xylinas , Joseph J. Crivelli , Niccolo Passoni , Evi Comploj
DOI: 10.1016/J.JURO.2013.01.089
关键词:
摘要: Purpose: To our knowledge the impact of body mass index on oncologic outcomes in nonmuscle invasive bladder cancer has not been evaluated. We hypothesized that higher is associated with worse patients clinical primary T1 high grade urothelial carcinoma bladder.Materials and Methods: retrospectively analyzed data from 892 7 centers. Patients were treated transurethral resection or without intravesical therapy. Body was as a continuous categorical variable (nonobese—body less than 30 kg/m2 vs obese—body greater). Disease progression defined development T2 tumor stage.Results: Median followup 42.8 months (IQR 56). Of 44.3% obese median 29.2 8). On univariable analyses age an increased risk dis...